E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis-Reference-Cited by-同舟云学术

E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis

Published:2015-11-30 Issue:1 Volume:126 Page:137-150
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Denechaud Pierre-Damien,Lopez-Mejia Isabel C.,Giralt Albert,Lai Qiuwen,Blanchet Emilie,Delacuisine Brigitte,Nicolay Brandon N.,Dyson Nicholas J.,Bonner Caroline,Pattou François,Annicotte Jean-Sébastien,Fajas Lluis

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference41 articles.

1. The E2F transcriptional network: old acquaintances with new faces

2. The CDK4–pRB–E2F1 pathway controls insulin secretion

3. E2Fs Regulate Adipocyte Differentiation

4. E2F transcription factor-1 regulates oxidative metabolism

5. Regulation of the PDK4 Isozyme by the Rb-E2F1 Complex

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations;Frontiers in Pharmacology;2024-07-30

2. E2F transcription factor-1 modulates expression of glutamine metabolic genes in mouse embryonic fibroblasts and uterine sarcoma cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-06

3. Identification of novel prognostic targets in acute kidney injury using bioinformatics and next generation sequencing data analysis;2024-03-17

4. CDK-4 regulates nucleolar size and metabolism at the cost of late-life fitness inC. elegans;2024-01-25

5. Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD);Frontiers in Molecular Medicine;2024-01-08